Advanced Renal Cancer
Video: Targeted Therapies for Kidney CancerSix new targeted therapies have improved treatment for Advanced, Metastatic Kidney Cancer in recent years. These include anti-angiogenesis inhibitors, which destroy blood vessels that surround tumors; and mTOR inhibitors, which interfere with a process that fuels growth in cancer cells. These new drugs have significantly increased survival for many patients and have fewer side effects than chemotherapy.
|
|
Podcast: Serious Cases of Kidney Cancer
Dr. Harry Drabkin, an internist specializing in Kidney Cancer at the Medical University of South Carolina, talks in detail about Kidney Cancer and emphasizes how the vascular nature of Kidney Cancer plays a role in the illness. Dr. Drabkin explains the staging process and the latest in drug development therapies for the treatment of Renal Cell Carcinoma.
|
Podcast: Kidney Cancer & Clinical Trials
Internist Specializing in Kidney Cancer, Dr. Harry Drabkin of the Medical University of South Carolina, discusses ongoing research projects and clinical trials for Kidney Cancer patients, and the role of blood vessels in the disease.
|
